Rituximab combined with cladribine or with cladribine and cyclophosphamide in heavily pretreated patients with indolent lymphoproliferative disorders and mantle cell lymphoma - Concepedia

Concepedia

Publication | Closed Access

Rituximab combined with cladribine or with cladribine and cyclophosphamide in heavily pretreated patients with indolent lymphoproliferative disorders and mantle cell lymphoma

50

Citations

32

References

2006

Year

Tadeusz Robak, Piotr Smolewski, Barbara Cebula‐Obrzut, Anna Szmigielska‐Kapłon, Krzysztof Chojnowski, Jerzy Z. Błoński

Abstract

The RC and RCC regimens were highly effective and well tolerated modalities of treatment in heavily pretreated patients with indolent lymphoproliferative disorders.

References

	Year	Citations

Page 1